Myricetin suppresses UVB-induced skin cancer by targeting Fyn

Sung Keun Jung1, Ki Won Lee, Sanguine Byun

  • 1Department of Agricultural Biotechnology, Seoul National University, Seoul, Republic of Korea.

Cancer Research
|July 18, 2008
PubMed

Insights

Myricetin, a natural compound, effectively prevents skin cancer by inhibiting Fyn kinase activity. This phytochemical suppresses UVB-induced inflammation and tumor development, offering a promising chemopreventive strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Dermatology

Background:

  • Skin cancer is the most common human cancer in Americans.
  • Myricetin, a phytochemical found in foods like red wine, shows anticancer-promoting activity.
  • Understanding the molecular mechanisms of skin cancer chemoprevention is crucial.

Purpose of the Study:

  • To investigate the chemopreventive effects of myricetin against UVB-induced skin carcinogenesis.
  • To elucidate the molecular targets and pathways through which myricetin exerts its effects.
  • To evaluate myricetin's efficacy in preclinical models of skin cancer.

Main Methods:

  • Utilized mouse skin epidermal JB6 P+ cells and in vivo mouse skin models.
  • Assessed UVB-induced cyclooxygenase-2 (COX-2) expression, activator protein-1 (AP-1) and nuclear factor-kappaB (NF-κB) activation.
  • Performed Western blot, kinase assays, pull-down assays, and molecular docking to analyze Fyn kinase activity and myricetin's interaction.

Main Results:

  • Myricetin suppressed UVB-induced COX-2 expression and the activation of AP-1 and NF-κB in a dose-dependent manner.
  • Myricetin directly inhibited Fyn kinase activity, attenuating downstream signaling pathways.
  • In vivo studies confirmed myricetin's ability to inhibit Fyn kinase and reduce UVB-induced skin tumor incidence.

Conclusions:

  • Myricetin demonstrates significant chemopreventive activity against UVB-induced skin carcinogenesis.
  • The primary mechanism involves the direct targeting and inhibition of Fyn kinase by myricetin.
  • Myricetin represents a promising natural agent for the prevention of skin cancer.

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...